RhumbLine Advisers’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,830
| Closed | -$4.7K | – | 4296 |
|
|
2024
Q2 | $4.7K | Hold |
1,830
| – | – | ﹤0.01% | 4095 |
|
|
2024
Q1 | $5.34K | Hold |
1,830
| – | – | ﹤0.01% | 3974 |
|
|
2023
Q4 | $4.23K | Hold |
1,830
| – | – | ﹤0.01% | 4011 |
|
|
2023
Q3 | $4.78K | Hold |
1,830
| – | – | ﹤0.01% | 3988 |
|
|
2023
Q2 | $6.55K | Buy |
+1,830
| New | +$6.55K | ﹤0.01% | 4037 |
|
|
2022
Q2 | – | Sell |
-34,046
| Closed | -$294K | – | 3197 |
|
|
2022
Q1 | $294K | Buy |
34,046
+9,611
| +39% | +$83K | ﹤0.01% | 2649 |
|
|
2021
Q4 | $349K | Buy |
24,435
+2,212
| +10% | +$31.6K | ﹤0.01% | 2659 |
|
|
2021
Q3 | $488K | Buy |
22,223
+8,241
| +59% | +$181K | ﹤0.01% | 2552 |
|
|
2021
Q2 | $187K | Buy |
+13,982
| New | +$187K | ﹤0.01% | 2928 |
|